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Abstract
The prevalence of nephrolihiasis and chronic kidney disease has risen over the past three decades, we sought to 
determine if person with a history of kidney stones have lower renal function relative to non stone formers. 
Methods: We conducted a case-control study utilizing 138 recurrent calcium kidney stone formers and 127 age 
and gender matched controls with no history of renal disease, all subjects were aged 30-55 years old, with no history 
of hypertension, diabetes mellitus, congestive heart failure and liver disease and also no urinary tract obstruction and 
medications can affect Glomerular Filtration Rate (GFR). 
We estimated GFR by Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology 
Collaboration (CKD-EP I) equations and categorized using cut points suggested by Kidney Disease Outcomes Quality 
Initiative (K/DOQI) guidelines.
Results:  Mean GFR in case group and control group was: 80.17(18.45) ml/min/1.73m2 and 83.80(15.75) ml/
min/1.73m2 respectively (P value: 0.09). Distribution of subjects among stone formers in stage I, II, III was 59(42.8%), 
71(51.4%) and 8(5.8%) and in control group was 67(52.8%), 59(46.4%) and 1(0.8%) respectively, (p: 0.03). There was 
an inverse correlation between GFR and number of passed stone but there was no significant correlation between 
history of extracorporeal shock wave lithotripsy (ESWL) or percutaneous nephrolithotomy (PCNL) and estimated GFR.
Conclusion: Recurrent calcium stone disease may be associated with nephron damage and an increased risk of 
chronic kidney disease.
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Introduction
Kidney stones are a common condition associated with significant 
morbidity, since up to 12% of men and 5% of women will have one 
symptomatic kidney stone by the age of 70 and recurrence rates are 
estimated at 50% [1].
Most people who experience an episode of stones will have at 
least one recurrence and some will suffer repeated bouts that may 
increase the likelihood of renal damage from obstruction or surgery 
[2]. Alarmingly, the incidence of Chronic Renal Insufficiency (CRI) is 
rising throughout the world [3]. With respect to patient outcomes, CRI 
patients suffer from an increased risk of mortality and cardiovascular 
disease relative to the general population [4,5]. While much is known 
about the pathogenesis and treatment of nephrolithiasis, the clinical 
consequences of stone disease remain relatively unidentified. In 
particular, little is known about the effect of stone disease on renal 
function. The hypothesis is that repeated transient obstruction 
from stone passage, treatments such as Extracorporeal Shock Wave 
Lithotripsy (ESWL), and possibly mineral deposits in the renal medulla 
may damage nephrons and reduce renal function [6-8].
We used data from a case-control study to measure associations 
between recurrent urinary calcium stones and loss of renal function. 
Methods 
We conducted a case-control study utilizing 138 cases with 
recurrent urinary calcium stones (based on history, radiologic studies 
and stone analysis) that were selected from our outpatient stone clinic 
and 127 community controls with no history of urinary stone.
All subjects were men, aged 30 to 55 years and also they had no 
established metabolic, gastrointestinal, Liver, cardiovascular, and 
endocrine disorders, they had no documented metabolic (such as 
diabetes mellitus), gastrointestinal, liver, cardiovascular (such as HTN 
and CHF), or endocrinological disorders. We excluded all the patients 
with urinary tract anomalies or obstruction, urinary tract infection, 
first single stone presentation, obesity (Body Mass Index > 30), and 
those who were on medication that may affect GFR. Furthermore, those 
patients with the excretion of cystine crystals in their urine were also 
excluded. The study was approved by the medical ethics committee, 
and all of the subjects gave their informed consents. “Recurrent stone 
former” was defined as either a recurrent stone event or an increase 
in the stone size during the past five years confirmed by imaging 
modalities. 
All subjects underwent metabolic evaluation, urine analysis and 
culture, kidney and urinary tract sonography. We estimated GFR by 
modification of Diet in Renal disease (MDRD) and Chronic Kidney 
Disease Epidemiology Collaboration (CKD-EP I) equations, [9,10] and 
categorized using cut points suggested by K/DOQI guidelines: stage I 
(GFR > 90ml/min/1.73m2) stage II (GFR: 60-89 mL/min/1.73m2), stage 
III (GFR: 30-59 mL/min/1.73m2), and we also adjusted GFR based on 
body surface area (BSA)(ml/min). 
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Statistical Analysis
The data was analyzed by using SPSS software version-17 (SPSS 
Inc, Chicago) for statistical analysis. GFR was expressed as Mean ± 
SD. We report Pearson correlation coefficient for investigating relation 
between GFR in two groups in all stages by using t test, and regression 
analysis for correlation of GFR and “the number of passed stone, ESWL 
and PCNL”. p<0.05 was considered statistically significant value. 
Results
The mean age of all subjects was 40 years (range, 30-55 years), all 
were male and white, there was no significant differences for age, BMI 
and serum creatinin in case and control groups (Table 1). 
Estimation of GFR by MDRD and CKD-EPI equations and also 
modification of estimated GFR for BSA does not show significant 
differences between case and control groups (Table 2).
Categorization of estimated GFR using cut points suggested by K/
DOQI guidelines show that recurrent stone formers experience a down 
ward shift in the distribution of GFR, resulting in a higher proportion 
of persons in the lower - tail of the distribution of GFR, this finding is 
especially significant in estimated GFR by CKD-EPI equation modified 
by BSA (p< 0.03) (Figures 1-4).
There is a significant negative correlation between estimated GFR 
and number of passed stone (r= -0.18, p=0.03), there is no significant 
correlation between history of ESWL or percutaneous nephrolithotomy 
(PCNL) and estimated GFR. 
There is no significant difference of estimated GFR between case 
and control groups according to BMI, the estimated GFR in case and 
control group in subjects with BMI < 25kg/m2 were 83.49(17.71) and 
89.76(18.14) ml/min respectively (p:0.10), and in subjects with BMI > 
25 were 92.21(23.12) and 95.49(19.24)ml/min respectively (p:0.31). 
In our subjects the prevalence of stage 3 CKD seems to be higher 
with the MDRD equation than CKD-EPI equation but is not significant.
Discussion
Our data suggest that recurrent kidney stones are associated with 
an increased risk of chronic kidney disease. In this study we exclude 
confounding factors and important risk factors for CKD in all subjects 
such as; history of HTN, DM, glomerulonehritis, cardiovascular 
disease, drugs and other underlying diseases. Even though there was 
a significant correlation between the number of passed stone and loss 
of GFR, there was no significant correlation between ESWL and PCNL 
procedures and loss of GFR. There was no significant differences in 
terms of GFR between recurrent stone former and control groups in 
BMI > 25kg/m2 and BMI < 25kg/m2 subjects.
Gillen and associates [11] have reported that the association 
between history of stones and estimated GFR depends on Body Mass 
Index (BMI) (P= 0.004). Mean estimated GFR in stone formers with a 
BMI >/=27 kg/m2 was 3.4 mL/min/1.73 m2 lower than that of similar 
Case
Mean (SD)
Control
Mean (SD) P-Value
Mean age, years 40.82(5.22) 39.48(6.50) 0.09
Mean BMI, kg/m2 26.53(2.82) 25.85(3.06) 0.06
Mean Serum creatinine mg/dL 1.16(0.26) 1.13(0.18) 0.36
No. of passed stone 10.85(16.91) - -
HX of ESWL 101(75%) - -
HX of PCNL 46(33%) - -
Table 1: Selected characteristics of 138 recurrent stone former and 127 control 
groups.
GFR calculation method Case (No.138)Mean (SD) 
Control 
(No.127)
Mean (SD)
P-Value 
MDRD  (mL/min/1.73m2) 77.66(19.03) 79.60(15.68) 0.34
CKD-EPI (ml/min/1.73m2) 80.17(18.45) 83.80(15.75) 0.09
MDRD adjusted by BSA (ml/min) 86.55(22.23) 88.77(19.30) 0.39
CKD-EPI adjusted by BSA (ml/min) 89.49(21.89) 93.41(18.99) 0.12
Table 2: Comparison of estimated GFR in recurrent stone former and control 
groups in different calculation methods.
Figure 1: Comparison of GFR in 138case and 127control groups (percent) 
based on MDRD (ml/min/1.73m2).
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Figure 2: Comparison of GFR in 138case and 127control groups (percent) 
based on modified MDRD (ml/min).
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Figure 3: Comparison of GFR in 138case and 127control groups (percent) 
based on CKD-EPI (ml/min/1.73m2).
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nonstone formers (95% CI -5.8, -1.1) (P= 0.005). No difference was 
found among persons with a BMI < 27 kg/m2. The probability of an 
overweight stone former having an estimated GFR between 30 and 
59 mL/min/1.73 m2 relative to a GFR above 90 mL/min/1.73 m2 was 
nearly twice that of a similar nonstone former [relative risk ratio (RRR) 
= 1.87, 95% CI 1.06, 3.30] [11]. 
 In our study BMI in all subjects were less than 30 kg/m2 and GFR 
was not different between case and control groups in BMI less or more 
than 25 kg/m2.
 In a case-control study utilizing 548 hospital cases and 514 age, 
race and gender matched has been revealed 16.8% of cases( with CKD) 
and 6.4% of controls with reported history of kidney stones, the odds 
ratios for chronic kidney disease (overall), diabetic nephropathy and 
interstitial nephritis for patients with kidney stones were 1.9 (95% CI: 
1.1, 3.3), 2.5 (95% CI: 0.87, 7.0) and 3.4 (95% CI: 1.5, 7.4), respectively 
[2].
In the study of Marangella et al. [12] they investigated the 
occurrence of chronic renal insufficiency in 171 patients with severe 
idiopathic calcium stone disease. The GFR level was in part predicted 
by the age of patients; however, stone disease was shown to induce a 
clear-cut influence in accelerating the natural worsening of GFR with 
age in a Case-control study for evaluation of risk factors for chronic 
kidney disease in persons with kidney stones, cases with CKD were 
significantly more likely (P < 0.05) than controls to have had a history 
of diabetes (41.5% vs. 17.0%), hypertension (71.7% vs. 49.1%), frequent 
urinary tract infections (22.6% vs. 6.6%), struvite stones (7.5% vs. 0%), 
ileal conduits, and obesity (BMI > 30), Although there was no evidence 
that shock wave lithotripsy was more common among kidney stone 
patients with CKD, open lithotomy was more prevalent (OR 2.18), 
It is not known if patients with diabetes or hypertension and kidney 
stones are more likely to develop CKD than patients with diabetes or 
hypertension but without kidney stones [13].
Few studies have addressed the problem of renal function loss in 
idiopathic calcium nephrolithiasis. In a survey of 2,000 patients, only 
33 patients (1.7%) experienced low- to moderate-grade RI [14].
The prevalence of stage 3 CKD is significantly higher with the 
MDRD study equation than CKD-EPI (11.04 vs. 7.98%) [9].
The current study suggests that recurrent calcium stone disease 
may be associated with nephron damage and an increased risk of 
chronic kidney disease.
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Figure 4: Comparison of GFR in 138case and 127control groups (percent) 
based on modified CKD-EPI (ml/min).
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